xml_file stringlengths 5 11 | reference_id stringlengths 1 7 | date_last_updated stringclasses 487
values | pubmed_id stringlengths 5 8 ⌀ | article_year int64 1.95k 2.03k ⌀ | article_title stringlengths 23 347 ⌀ | journal_title stringlengths 3 197 ⌀ | authors stringlengths 5 2.35k ⌀ | epitope_id stringlengths 1 7 ⌀ | epitope_name stringlengths 1 85 ⌀ | epitope_structure_type stringclasses 8
values | epitope_chemical_type stringclasses 18
values | linear_sequence stringlengths 1 829 ⌀ | linear_sequence_length int64 1 829 ⌀ | discontinuous_residues stringlengths 2 419 ⌀ | starting_position int64 0 34.8k ⌀ | ending_position int64 3 34.8k ⌀ | source_organism_id stringlengths 1 8 ⌀ | source_molecule_genbank_id stringlengths 4 14 ⌀ | reference_region stringlengths 2 409 ⌀ | epitope_structure_defines stringclasses 4
values | epitope_evidence_code stringclasses 6
values | assay_category stringclasses 4
values | assay_id stringlengths 2 8 | assay_type_id stringclasses 412
values | assay_location_of_data stringlengths 4 126 ⌀ | qualitative_measurement stringclasses 5
values | is_positive bool 2
classes | quantitative_measurement stringlengths 3 25 ⌀ | host_organism_id stringclasses 729
values | host_sex stringclasses 2
values | host_age stringlengths 1 39 ⌀ | disease_state stringclasses 666
values | mhc_allele_id stringclasses 868
values | mhc_allele_types_present stringlengths 1 150 ⌀ | cell_type stringclasses 41
values | cell_tissue_type stringclasses 49
values | cell_culture_conditions stringclasses 9
values | antigen_evidence_code stringclasses 6
values | immunogen_evidence_code stringclasses 6
values | assay_comments stringclasses 0
values | split_bucket int64 1 9 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74526 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YKVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207920 | 417 | Table 2, Table 3 | Negative | false | 370.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74949 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAKQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207931 | 417 | Table 2 | Positive-High | true | 29.5 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74949 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAKQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207932 | 417 | Table 2 | Positive-Intermediate | true | 165.4 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74949 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAKQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207933 | 417 | Table 2 | Positive-High | true | 33.4 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74949 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAKQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207934 | 417 | Table 2 | Positive-High | true | 18.7 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74949 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAKQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207935 | 417 | Table 2 | Positive-High | true | 23.2 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74949 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAKQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207936 | 417 | Table 2 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74952 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQAKV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207943 | 417 | Table 2 | Positive-High | true | 20.9 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74952 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQAKV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207946 | 417 | Table 2 | Positive-High | true | 5.5 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74952 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQAKV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207944 | 417 | Table 2 | Positive-High | true | 33.1 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74952 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQAKV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207945 | 417 | Table 2 | Positive-High | true | 27.1 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74952 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQAKV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207947 | 417 | Table 2 | Positive-High | true | 26.5 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74952 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQAKV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207948 | 417 | Table 2 | Positive-Intermediate | true | 307.7 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74953 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATD | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207949 | 417 | Table 4 | Negative | false | 500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74953 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATD | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207950 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74953 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATD | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207952 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74953 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATD | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207953 | 417 | Table 4 | Negative | false | 370.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74953 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATD | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207951 | 417 | Table 4 | Negative | false | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74953 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATD | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207954 | 417 | Table 4 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74954 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATF | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207959 | 417 | Table 4 | Negative | false | 370.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74954 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATF | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207960 | 417 | Table 4 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74954 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATF | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207955 | 417 | Table 4 | Positive-Intermediate | true | 75.8 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74954 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATF | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207956 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74954 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATF | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207958 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74954 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATF | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207957 | 417 | Table 4 | Positive-Intermediate | true | 227.3 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74955 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATI | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207964 | 417 | Table 4 | Positive-High | true | 14.4 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74955 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATI | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207965 | 417 | Table 4 | Positive-High | true | 21.8 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74955 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATI | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207962 | 417 | Table 4 | Positive-High | true | 30.8 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74955 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATI | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207966 | 417 | Table 4 | Positive-Low | true | 533.3 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74955 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATI | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207961 | 417 | Table 4 | Positive-High | true | 22.8 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74955 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATI | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207963 | 417 | Table 4 | Positive-High | true | 16.7 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74956 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATK | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207969 | 417 | Table 2, Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74956 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATK | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207971 | 417 | Table 2, Table 4 | Negative | false | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74956 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATK | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207973 | 417 | Table 2, Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74956 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATK | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207977 | 417 | Table 4, Table 2 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74956 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATK | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207967 | 417 | Table 2, Table 4 | Negative | false | 500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74956 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATK | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207975 | 417 | Table 2, Table 4 | Negative | false | 370.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74957 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATL | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207984 | 417 | Table 4 | Positive-Low | true | 645.2 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74957 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATL | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207981 | 417 | Table 4 | Positive-High | true | 13.9 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74957 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATL | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207980 | 417 | Table 4 | Positive-High | true | 4.3 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74957 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATL | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207982 | 417 | Table 4 | Positive-High | true | 4.3 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74957 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATL | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207983 | 417 | Table 4 | Positive-High | true | 9.8 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74957 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATL | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207979 | 417 | Table 4 | Positive-High | true | 5.3 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74958 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATP | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207985 | 417 | Table 4 | Negative | false | 500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74958 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATP | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207986 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74958 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATP | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207988 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74958 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATP | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207989 | 417 | Table 4 | Negative | false | 370.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74958 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATP | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207990 | 417 | Table 4 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74958 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATP | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207987 | 417 | Table 4 | Negative | false | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74959 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATQ | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207992 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74959 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATQ | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207994 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74959 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATQ | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207995 | 417 | Table 4 | Negative | false | 370.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74959 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATQ | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207993 | 417 | Table 4 | Negative | false | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74959 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATQ | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207996 | 417 | Table 4 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74959 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATQ | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207991 | 417 | Table 4 | Negative | false | 500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74960 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATT | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207998 | 417 | Table 4 | Positive-Intermediate | true | 358.4 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74960 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATT | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208000 | 417 | Table 4 | Positive-Intermediate | true | 253.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74960 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATT | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207997 | 417 | Table 4 | Positive-High | true | 31.3 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74960 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATT | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208001 | 417 | Table 4 | Positive-Intermediate | true | 108.9 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74960 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATT | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208002 | 417 | Table 4 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74960 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQATT | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207999 | 417 | Table 4 | Positive-Intermediate | true | 91.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74961 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | YLVAYQATV | 9 | null | 1,585 | 1,593 | 31645 | P29846.3 | null | Exact Epitope | Not determined | MhcBinding | 208014 | 417 | Table 4 | Positive-High | true | 8.5 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74961 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | YLVAYQATV | 9 | null | 1,585 | 1,593 | 31645 | P29846.3 | null | Exact Epitope | Not determined | MhcBinding | 208006 | 417 | Table 2 | Positive-High | true | 4.3 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74961 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | YLVAYQATV | 9 | null | 1,585 | 1,593 | 31645 | P29846.3 | null | Exact Epitope | Not determined | MhcBinding | 208018 | 417 | Table 4 | Negative | false | 2300.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74961 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | YLVAYQATV | 9 | null | 1,585 | 1,593 | 31645 | P29846.3 | null | Exact Epitope | Not determined | MhcBinding | 208019 | 417 | Table 2 | Positive-High | true | 40.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74961 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | YLVAYQATV | 9 | null | 1,585 | 1,593 | 31645 | P29846.3 | null | Exact Epitope | Not determined | MhcBinding | 208003 | 417 | Table 2 | Positive-High | true | 5.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74961 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | YLVAYQATV | 9 | null | 1,585 | 1,593 | 31645 | P29846.3 | null | Exact Epitope | Not determined | MhcBinding | 208008 | 417 | Table 4 | Positive-High | true | 5.2 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74961 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | YLVAYQATV | 9 | null | 1,585 | 1,593 | 31645 | P29846.3 | null | Exact Epitope | Not determined | MhcBinding | 208009 | 417 | Table 2, Table 4 | Positive-High | true | 10.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74961 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | YLVAYQATV | 9 | null | 1,585 | 1,593 | 31645 | P29846.3 | null | Exact Epitope | Not determined | MhcBinding | 208012 | 417 | Table 2 | Positive-High | true | 4.3 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74961 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | YLVAYQATV | 9 | null | 1,585 | 1,593 | 31645 | P29846.3 | null | Exact Epitope | Not determined | MhcBinding | 208013 | 417 | Table 3 | Positive-High | true | 22.7 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74961 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | YLVAYQATV | 9 | null | 1,585 | 1,593 | 31645 | P29846.3 | null | Exact Epitope | Not determined | MhcBinding | 208015 | 417 | Table 2, Table 3 | Positive-High | true | 3.7 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74961 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | YLVAYQATV | 9 | null | 1,585 | 1,593 | 31645 | P29846.3 | null | Exact Epitope | Not determined | MhcBinding | 208020 | 417 | Table 3 | Positive-Low | true | 1379.3103 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74965 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQKTV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208027 | 417 | Table 2 | Positive-Low | true | 930.2 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74965 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQKTV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208022 | 417 | Table 2 | Positive-Intermediate | true | 92.6 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74965 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQKTV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208024 | 417 | Table 2 | Positive-High | true | 31.3 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74965 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQKTV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208025 | 417 | Table 2 | Positive-High | true | 30.8 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74965 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQKTV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208023 | 417 | Table 2 | Positive-Intermediate | true | 268.8 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74965 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLVAYQKTV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208026 | 417 | Table 2 | Positive-Intermediate | true | 57.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 75424 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YPVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208036 | 417 | Table 3 | Negative | false | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 75424 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YPVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208035 | 417 | Table 3 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 75424 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YPVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208038 | 417 | Table 3 | Negative | false | 370.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 75424 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YPVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208039 | 417 | Table 3 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 75424 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YPVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208034 | 417 | Table 3 | Negative | false | 500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 75424 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YPVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208037 | 417 | Table 3 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 75564 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YQVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208044 | 417 | Table 3 | Positive-High | true | 6.5 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 75564 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YQVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208041 | 417 | Table 3 | Positive-High | true | 7.9 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 75564 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YQVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208042 | 417 | Table 3 | Positive-High | true | 21.8 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 75564 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YQVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208040 | 417 | Table 3 | Positive-High | true | 5.5 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 75564 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YQVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208043 | 417 | Table 3 | Positive-High | true | 4.3 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 75564 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YQVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208045 | 417 | Table 3 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 76198 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YTVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208048 | 417 | Table 3 | Positive-Intermediate | true | 91.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 76198 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YTVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208046 | 417 | Table 3 | Positive-High | true | 8.7 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 76198 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YTVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208047 | 417 | Table 3 | Positive-High | true | 18.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 76198 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YTVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208049 | 417 | Table 3 | Positive-High | true | 12.7 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 76198 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YTVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208050 | 417 | Table 3 | Positive-High | true | 5.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 76198 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YTVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208051 | 417 | Table 3 | Positive-High | true | 40.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 76432 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YVVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208052 | 417 | Table 3 | Positive-High | true | 17.9 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 76432 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YVVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208053 | 417 | Table 3 | Positive-High | true | 15.4 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 76432 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YVVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208055 | 417 | Table 3 | Positive-High | true | 12.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 76432 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YVVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 208057 | 417 | Table 3 | Positive-Intermediate | true | 58.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.